Schedule of other significant items (Details) - USD ($) |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Segment Reporting [Line Items] | ||
| Interest expense | $ 58,188 | $ 63,767 |
| Depreciation and amortization | 113,444 | 88,201 |
| Capital expenditure | 259,135 | 23,222 |
| Property Management Services [Member] | ||
| Segment Reporting [Line Items] | ||
| Interest expense | 895 | 1,570 |
| Depreciation and amortization | 338 | 2,170 |
| Capital expenditure | 23,222 | |
| Holistic Wellness Consumer Products And Services [Member] | ||
| Segment Reporting [Line Items] | ||
| Interest expense | 1,372 | |
| Depreciation and amortization | 31,885 | 11,027 |
| Capital expenditure | 259,135 | |
| Others [Member] | ||
| Segment Reporting [Line Items] | ||
| Interest expense | 57,293 | |
| Depreciation and amortization | 81,221 | |
| Capital expenditure | ||
| Unallocated [Member] | ||
| Segment Reporting [Line Items] | ||
| Interest expense | 61,133 | |
| Depreciation and amortization | 75,004 | |
| Capital expenditure | ||
| X | ||||||||||
- Definition Amount of capital expenditure attributable to discontinued operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as other. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|